日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Gut ecosystem dysfunction in parkinson's disease: deciphering faecal metabolome-metagenome links for novel diagnostic panels

帕金森病肠道生态系统功能障碍:解析粪便代谢组-宏基因组关联,构建新型诊断方案

Qian, Yiwei; Xu, Shaoqing; He, Xiaoqin; Lai, Yiqiu; Zhang, Yi; Mo, Chengjun; Ai, Penghui; Yang, Xiaodong; Xiao, Qin

Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson's disease

药物微生物组学:一个有助于优化帕金森病药物治疗的新领域

Zhang, Yi; Mo, Chengjun; Ai, Penghui; He, Xiaoqin; Xiao, Qin; Yang, Xiaodong

Targeted Gut Microbiota Modulation Enhances Levodopa Bioavailability and Motor Recovery in MPTP Parkinson's Disease Models

靶向调节肠道菌群可提高左旋多巴的生物利用度并改善MPTP帕金森病模型中的运动功能恢复

Ai, Penghui; Xu, Shaoqing; Yuan, Yuan; Xu, Ziqi; He, Xiaoqin; Mo, Chengjun; Zhang, Yi; Yang, Xiaodong; Xiao, Qin

Contribution of dopaminergic polymorphisms to levodopa treatment response and drug concentration in Chinese patients with Parkinson's disease

多巴胺能多态性对中国帕金森病患者左旋多巴治疗反应和药物浓度的影响

He, Xiaoqin; Shi, Kai; Mo, Chengjun; Zhang, Yi; Xiao, Qin; Yang, Xiaodong

Association between Fecal Bile Acids and Levodopa Response in Patients with Parkinson's Disease

粪便胆汁酸与帕金森病患者左旋多巴反应之间的关联

He, Xiaoqin; Lai, Yiqiu; Mo, Chengjun; Zhang, Yi; Ai, Penghui; Xu, Shaoqing; Qian, Yiwei; Xiao, Qin; Yang, Xiaodong

Plasma branched-chain and aromatic amino acids correlate with the gut microbiota and severity of Parkinson's disease

血浆支链氨基酸和芳香族氨基酸与肠道菌群和帕金森病严重程度相关

Zhang, Yi; He, Xiaoqin; Qian, Yiwei; Xu, Shaoqing; Mo, Chengjun; Yan, Zheng; Yang, Xiaodong; Xiao, Qin

Findings in Chinese Patients With Parkinson's Disease: A Content Analysis From the SML Study

中国帕金森病患者的研究结果:来自SML研究的内容分析

Qian, Yiwei; Zhang, Yi; He, Xiaoqin; Xu, Shaoqing; Yang, Xiaodong; Mo, Chengjun; Lu, Xiaomeng; Qiu, Mengjuan; Xiao, Qin

Increased interleukin-18 level contributes to the development and severity of ischemic stroke.

白细胞介素-18 水平升高会导致缺血性中风的发生和加重

Hao Yong, Ding Jie, Hong Ronghua, Bai Shuwei, Wang Ze, Mo Chengjun, Hu Qiang, Li Zezhi, Guan Yangtai